Prevalence and clinical correlates of pre-operative glucose homeostasis in patients with acromegaly
Authors:
- 25 February 2026
- journal article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 84, 101686
Abstract
No abstract availableKeywords
Funding Information
- Taipei Veterans General Hospital (V107C-066)
- National Science and Technology Council (NSTC 111-2314-B-A49-064-)
This publication has 17 references indexed in Scilit:
- Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and managementNature Reviews Endocrinology, 2024
- Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelinesPituitary, 2023
- Secondary diabetes mellitus in acromegalyEndocrine, 2023
- Acromegaly: pathogenesis, diagnosis, and managementThe Lancet Diabetes & Endocrinology, 2022
- Effect of Diabetes on Morbidity and Mortality in Patients With AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2022
- Growth Hormone and ObesityEndocrinology and Metabolism Clinics of North America, 2020
- Natural History of Acromegaly: Incidences, Re-operations, Cancers, and Mortality Rates in a National CohortNeuroendocrinology, 2019
- Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patientsPituitary, 2013
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human SubjectsEndocrine Reviews, 2009
- Pathogenesis of type 2 diabetes mellitusMedical Clinics of North America, 2004